Company Quick10K Filing
Liberty Expedia
10-Q 2019-03-31 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-02-08
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-02
10-K 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-03
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-03
8-K 2019-07-26
8-K 2019-06-28
8-K 2019-06-05
8-K 2019-04-15
8-K 2018-06-19
8-K 2018-05-18
8-K 2018-03-06

Liberty Expedia Financials

LEXE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450 5.1 1% 3,541 3,244 0 0 39 78 398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,497 0 0 0 0 -308
SQL Technologies (SQFL) 18% 1.5 0% 7 30 9 2 0 2 3
2-Track Global (TTG)
GB Sciences (GBLX) 23 -23% -1.8 -56% 30 16 4 -1 -17 -13 23
Nemaura Medical (NMRD) 158 -32.0 -182% 3 3 0 0 -5 -5 156
Monroe Bank and Trust (MBTF) 232 -6.6 1% 1,327 1,191 0 0 10 16 -107
Solis Tek (SLTK) 44 51% -25.8 -163% 1 7 2 1 -2 -2 44
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -11 1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Cash01,8512,5642,9803,3503,7663,5333,2012,7744,215
Accounts Receivable01,3451,5821,8141,8392,2572,3632,2982,1542,621
Inventory4140
PP&E578989601,0641,1481,2491,3199741,481967
Assets1,10133,98235,62036,74636,95235,76035,55433,06931,89734,646
Accounts Payable8
Long-Term Debt273,7953,7863,8994,9014,8634,8144,2944,2434,223
Liabilities42913,69015,53216,30316,21517,05817,34915,10714,38017,341
Stockholders' Equity6732,7632,7102,6852,7082,5752,5162,4412,4012,301
Income Statement ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue971,2562,2302,6463,0292,5742,9403,3312,6042,661
Cost of Revenue70284400414434
Gross Profit269721,7653,9152,544
R&D
SG&A131,4481,6111,5601,7121,7311,6971,730
Tax14-454-154-82-23-65-46-120-60
Net Income292,052-357-225123-44-27-42-15-64
Cash Flow ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating1261,677-4481,676812-3722,151
Cash Investing1,603-952-177-730-707777-724
Cash Financing155-43950-228-215-72425